There has also been research showing that ATRA inhibits ERα protein expression in breast cancer cells, and breast cancers resistant to tamoxifen may be inhibited by the drug combination with tamoxifen [19], but the combination effect and mechanism in ovarian cancer are still unclear. This evidence concerns the gene ESR1 and breast carcinoma.